Abstract:Human respiratory viruses have an enormous impact on national health systems, societies, and economy due to the rapid airborne transmission and epidemic spread of such pathogens, while effective specific antiviral drugs to counteract infections are still lacking. Here, we identified two Keggin-type polyoxometalates (POMs), [TiW 11 CoO 40 ] 8- (TiW 11 Co) and [Ti 2 PW 10 O 40 ] 7- (Ti 2 PW 10 ), endowed with broad-spectrum activity against enveloped and non-enveloped human respiratory viruses, i.e., coronavirus (HCoV-OC43), rhinovirus (HRV-A1), respiratory syncytial virus (RSV-A2), and adenovirus (AdV-5). Ti 2 PW 10 showed highly favorable selectivity indexes against all tested viruses (SIs >700), and its antiviral potential was further investigated against human coronaviruses and rhinoviruses. This POM was found to inhibit replication of multiple HCoV and HRV strains, in different cell systems. Ti 2 PW 10 did not affect virus binding or intracellular viral replication, but selectively inhibited the viral entry. Serial passaging of virus in presence of the POM revealed a high barrier to development of Ti 2 PW 10 -resistant variants of HRV-A1 or HCoV-OC43. Moreover, Ti 2 PW 10 was able to inhibit HRV-A1 production in a 3D model of the human nasal epithelium and, importantly, the antiviral treatment did not determine cytotoxicity or tissue damage. A mucoadhesive thermosensitive in situ hydrogel formulation for nasal delivery was also developed for Ti 2 PW 10 . Overall, good biocompatibility on cell lines and human nasal epithelia, broad-spectrum activity, and absence of antiviral resistance development reveal the potential of Ti 2 PW 10 as an antiviral candidate for the development of a treatment of acute respiratory viral diseases, warranting further studies to identify the specific target/s of the polyanion and assess its clinical potential.

Anti-RNA Virus Activity of Polyoxometalates.

Polyoxometalate exerts broad-spectrum activity against human respiratory viruses hampering viral entry.

Anti-flavivirus Activity of Polyoxometalate

Sodium Polyoxotungstate Inhibits the Replication of Influenza Virus by Blocking the Nuclear Import of vRNP

The development of polyoxometalates as antivirus drugs

Molecular Simulation Study of the Binding Mechanism of [Α-Pti2w10o40]7− for Its Promising Broad-Spectrum Inhibitory Activity to FluV-A Neuraminidase

Inhibition of Hepatitis C Virus Infection by Polyoxometalates

Anti-influenza A(H5N1) virus activities of a novel polyoxometalate in vitro and in vivo

Studies on the interactions of Ti-containing polyoxometalates (POMs) with SARS-CoV 3CLpro by molecular modeling.

A novel application of Ti‐substituted polyoxometalates: Anti‐inflammatory activity in OVA‐induced asthma murine model

Synthesis and Anti-Hiv-1 Activity Evaluation of Keggin-type Polyoxometalates with Amino Acid As Organic Cations

Synthesis and anti-influenza virus activity of polyoxometalates containing amantadine

Antibacterial Activity of Polyoxometalates Against Moraxella catarrhalis

Genotoxicity and Acute and Subchronic Toxicity Studies of a Bioactive Polyoxometalate in Wistar Rats.

A Novel Application of Ti-Substituted Polyoxometalates: Anti-Inflammatory Activity in OVA-Induced Asthma Murine Model

Inhibition of Multiple Subtypes of Influenza A Virus in Cell Cultures with Morpholino Oligomers

Vanadium-substituted Keggin structured polyoxometalate combined with fluconazole in α-SiW11V-FKZ for efficient bacterial inhibition

Antisense Phosphorodiamidate Morpholino Oligomers As Novel Antiviral Compounds

Polyallylamine antiviral activity against influenza and acute respiratory viral infection in various cell cultures

Promising application of polyoxometalates in the treatment of cancer, infectious diseases and Alzheimer's disease

Polydopamine-based nanomedicines for efficient antiviral and secondary injury protection therapy